3BDO, a butyrolactone derivative, could target FKBP1A and activate the mTOR signaling pathway. It inhibits autophagy in HUVECs.
For research use only. We do not sell to patients.
Name | 3BDO |
---|---|
Iupac Chemical Name | Pentonic acid, 2,3-dideoxy-5-O-(2-nitrophenyl)-2-(phenylmethyl)- |
Synonyms | 3BDO |
Molecular Formula | C18H19NO6 |
Molecular Weight | 345.351 |
Smile | OC(COC1=CC=CC=C1[N+]([O-])=O)CC(CC2=CC=CC=C2)C(O)=O |
InChiKey | HLYXFAINZWNIRV-UHFFFAOYSA-N |
InChi | InChI=1S/C18H19NO6/c20-15(12-25-17-9-5-4-8-16(17)19(23)24)11-14(18(21)22)10-13-6-2-1-3-7-13/h1-9,14-15,20H,10-12H2,(H,21,22) |
CAS Number | 890405-51-3 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Off-white solid to white solid |
---|---|
Purity | >98% |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |